A new sequential HRT regimen (Climen‐Schering) consisting of a combination of estradiol valerate (EV)(2 mg. days 1‐11) and cyproterone acetate (CPA; 1 mg) plus EV (2 mg, days 12‐ 21) followed by a 7‐day drug‐free interval was tested, The interesting aspect of this regimen is the use of CPA, a strong progestogen with antiandrogenic properties.
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Clinical Data
OMODEI, Umberto;
1995-01-01
Abstract
A new sequential HRT regimen (Climen‐Schering) consisting of a combination of estradiol valerate (EV)(2 mg. days 1‐11) and cyproterone acetate (CPA; 1 mg) plus EV (2 mg, days 12‐ 21) followed by a 7‐day drug‐free interval was tested, The interesting aspect of this regimen is the use of CPA, a strong progestogen with antiandrogenic properties.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
